Clinical trial
Leucine and Skeletal Muscle Disuse: Clinical Anti-Atrophic Effectiveness and Related Mechanisms
NCT01192009 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Leucine and Skeletal Muscle Disuse: Clinical Anti-Atrophic Effectiveness and Related Mechanisms
- Lead sponsor
- University of Sao Paulo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- February 28, 2013
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disuse atrophy